thegreenhand
Bluelight Crew
Drug policy group condemns psychedelic research association for response to B.C. sex assault claims
Bethany LindsayCBC
12 May 2022
Excerpt:
A national drug policy advocacy organization is condemning how a prominent psychedelic research body responded to a B.C. woman's allegations of sexual and physical abuse during clinical trials for MDMA-assisted psychotherapy.
The Canadian Drug Policy Coalition released a statement Thursday expressing "unequivocal solidarity" with Meaghan Buisson and calling on the Multidisciplinary Association for Psychedelic Studies (MAPS) and its Vancouver-based affiliate MAPS Canada to take public responsibility for causing harm.
"While [Buisson's] formal account of sexual assault ought to have resulted in swift, thorough, and decisive action, there are reports that it was instead ignored, minimized, suppressed, and used to coerce her into a position of extreme social and economic precarity," the statement reads.